Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
暂无分享,去创建一个
Mitsuhiro Nakamura | Masahiro Hiraoka | Takashi Mizowaki | Yukinori Matsuo | Kenji Takayama | Yoshiki Norihisa | M. Hiraoka | M. Narabayashi | K. Takayama | T. Mizowaki | Y. Matsuo | Y. Norihisa | Masaru Narabayashi | Katsuyuki Sakanaka | K. Sakanaka | M. Nakamura
[1] D. Hallahan,et al. Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy. , 2007, Medical physics.
[2] T. Krieger,et al. Monte Carlo- versus pencil-beam-/collapsed-cone-dose calculation in a heterogeneous multi-layer phantom , 2005, Physics in medicine and biology.
[3] Luca Cozzi,et al. Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations , 2006, Physics in medicine and biology.
[4] Masahiro Hiraoka,et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.
[5] H. Shirato,et al. Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403) , 2006, Physics in medicine and biology.
[6] Thomas Krieger,et al. Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. , 2005, International journal of radiation oncology, biology, physics.
[7] J. Petersen,et al. Comparison of two dose calculation methods applied to extracranial stereotactic radiotherapy treatment planning. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] Vanessa Panettieri,et al. SBRT of lung tumours: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systems , 2007, Physics in medicine and biology.
[9] C. Hurkmans,et al. Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose , 2008, Radiation oncology.
[10] I. Kawrakow,et al. Electron beam dose calculations with the VMC algorithm and the verification data of the NCI working group. , 1997, Physics in medicine and biology.
[11] E. Smit,et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[12] J. Wong,et al. On methods of inhomogeneity corrections for photon transport. , 1990, Medical physics.
[13] Michael Flentje,et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. , 2004, International journal of radiation oncology, biology, physics.
[14] I. Lax,et al. Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions , 2006, Acta oncologica.
[15] Stephanie Frost,et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. , 2003, Chest.
[16] H. Geinitz,et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC) , 2006, Acta oncologica.
[17] Umberto Ricardi,et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. , 2010, Lung cancer.
[18] Hiroki Shirato,et al. STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .
[19] M. Fippel. Fast Monte Carlo dose calculation for photon beams based on the VMC electron algorithm. , 1999, Medical physics.
[20] Jose Belderbos,et al. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Shinichi Shimizu,et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. , 2003, International journal of radiation oncology, biology, physics.
[22] Andrea Bezjak,et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.
[23] F. Lohr,et al. Optimization of extracranial stereotactic radiation therapy of small lung lesions using accurate dose calculation algorithms , 2006, Radiation oncology.
[24] Angelika Hoess,et al. Stereotactic single‐dose radiotherapy (radiosurgery) of early stage nonsmall‐cell lung cancer (NSCLC) , 2007, Cancer.
[25] R. Onimaru,et al. A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-small Cell Lung Cancer: Japan Clinical Oncology Group (JCOG0403) , 2010 .
[26] E. Kunieda,et al. Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[27] J. Wong,et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. , 2001, International journal of radiation oncology, biology, physics.
[28] A. Boyer,et al. Tissue Inhomogeneity Corrections for Megavoltage Photon Beams , 2004 .